UBS Group’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $110K | Sell |
|
|||||
|
2025
Q2 | $166K | Sell |
|
|||||
|
2025
Q1 | $461K | Sell |
|
|||||
|
2024
Q4 | $918K | Buy |
|
|||||
|
2024
Q3 | $399K | Buy |
|
|||||
|
2024
Q2 | $311K | Sell |
|
|||||
|
2024
Q1 | $333K | Buy |
|
|||||
|
2023
Q4 | $339K | Buy |
|
|||||
|
2023
Q3 | $210K | Sell |
|
|||||
|
2023
Q2 | $207K | Buy |
|
|||||
|
2023
Q1 | $21.1K | Buy |
|
|||||
|
2022
Q4 | $17K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $8K | Sell |
|
|||||
|
2022
Q1 | $13K | Sell |
|
|||||
|
2021
Q4 | $48K | Buy |
|